How should I manage a patient with hypertriglyceridemia (triglycerides 287 mg/dL) and low HDL cholesterol (31 mg/dL)?

Treatment Approach for Triglycerides 287 mg/dL and HDL 31 mg/dL

Start a moderate-to-high intensity statin immediately as first-line therapy, implement aggressive lifestyle modifications focusing on weight loss and carbohydrate restriction, and after achieving LDL control on statin therapy, consider adding icosapent ethyl if you have established cardiovascular disease or diabetes with additional risk factors. 1

Initial Assessment and Risk Stratification

First, determine your cardiovascular risk category and identify secondary causes:

• Check for diabetes, metabolic syndrome, hypothyroidism, chronic kidney/liver disease, and medications that raise triglycerides (thiazides, beta-blockers, estrogens, corticosteroids) 1
• Calculate your 10-year ASCVD risk or determine if you have established cardiovascular disease
• Obtain a complete fasting lipid panel including LDL-C calculation (Total cholesterol - HDL - [TG/5])
• Your non-HDL cholesterol target should be <130 mg/dL (calculated as total cholesterol minus HDL) 2, 3

Immediate Lifestyle Interventions (Foundation of All Treatment)

These are not optional—they must be implemented aggressively:

• Weight loss if overweight/obese: Even 5-10% body weight reduction significantly lowers triglycerides
• Carbohydrate restriction: Reduce total carbohydrates, especially refined sugars and simple carbs to <7% of total calories 2, 3
• Eliminate alcohol completely: Alcohol directly raises triglycerides 2, 3
• Reduce saturated fat to <7% of total calories and trans fats to <1% 2, 3
• Increase physical activity: Aim for 150 minutes/week of moderate-intensity aerobic exercise 2, 3
• Add viscous fiber >10 g/day and plant stanols/sterols 2 g/day 2, 3

Consider referral to a registered dietitian nutritionist for medical nutrition therapy—this is underutilized but critical for complex lipid management 4.

Pharmacologic Management Algorithm

Step 1: Statin Therapy (First-Line for Everyone)

Initiate statin therapy regardless of your LDL level because:

• Your HDL is severely low (<40 mg/dL for men, <50 mg/dL for women)
• Your triglycerides are in the moderate range (200-499 mg/dL category)
• Statins reduce cardiovascular events and modestly improve both triglycerides and HDL 5, 1

Statin intensity based on your risk:

• Age 40-75 with diabetes or ASCVD risk factors: Moderate-intensity statin 1
• Age 50-70 with multiple risk factors or established ASCVD: High-intensity statin 1
• Established ASCVD at any age: High-intensity statin 1

Target LDL-C <100 mg/dL, ideally <70 mg/dL if high risk 2, 3

Step 2: After Achieving LDL Control on Statin

Once your LDL is at goal on maximally tolerated statin therapy, reassess your triglycerides. If they remain elevated (135-499 mg/dL) AND you meet specific criteria, consider adding:

Icosapent ethyl (purified EPA) 4 grams daily if you have:

• Established ASCVD, OR
• Diabetes with additional cardiovascular risk factors
• This is the ONLY triglyceride-lowering therapy proven to reduce cardiovascular events when added to statins 1, 6

Step 3: Alternative Agents (Limited Evidence)

Fibrates or niacin are reasonable options ONLY after statin therapy for:

• HDL <40 mg/dL (men) or <50 mg/dL (women) 2, 3
• Triglycerides >200 mg/dL 2, 3

However, critical caveats:

• Statin + fibrate combination increases myopathy/rhabdomyolysis risk—use lowest effective statin dose if combining; fenofibrate is safer than gemfibrozil with statins 7, 1
• Statin + niacin does NOT reduce cardiovascular events and may increase stroke risk—generally NOT recommended 7, 1
• Fibrate monotherapy (without statin) showed no cardiovascular benefit in the ACCORD trial except possibly in men with TG ≥204 mg/dL AND HDL ≤34 mg/dL 7, 1

Monitoring Strategy

• Recheck lipid panel 4-12 weeks after starting or changing therapy 1
• Annual lipid panels once stable 1
• Monitor for statin side effects (muscle symptoms, liver enzymes)
• If combining statin + fibrate, monitor closely for myopathy symptoms

Key Pitfalls to Avoid

1. Don't start fibrates or niacin before statins—statins are first-line for cardiovascular risk reduction 1
2. Don't use gemfibrozil with statins—use fenofibrate if fibrate needed due to lower rhabdomyolysis risk 7, 1
3. Don't ignore lifestyle modifications—pharmacotherapy alone is insufficient 2, 3, 1
4. Don't use bile acid sequestrants when triglycerides >200 mg/dL—they can worsen hypertriglyceridemia 2, 3
5. Don't assume dietary supplements (over-the-counter fish oil or niacin) are equivalent to prescription formulations—they are not 2

Special Consideration: Pancreatitis Risk

Your triglycerides at 287 mg/dL do NOT pose acute pancreatitis risk (that threshold is ≥500 mg/dL, especially ≥1,000 mg/dL) 6, 8. Your primary concern is cardiovascular disease prevention, not pancreatitis.